These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 16312407)
41. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454 [TBL] [Abstract][Full Text] [Related]
43. Multiresistant Haemophilus influenzae in Belgium. Piot P; Van Dyck E; Verschraegen G; Claeys G; Lauwers S; Lontie M; Verbist L; Van Landuyt H Acta Clin Belg; 1983; 38(4):271-2. PubMed ID: 6605640 [No Abstract] [Full Text] [Related]
44. Comparison of tube and plate methods for testing combinations of antibiotics against Haemophilus influenzae. McBryde VE; Dowling HF; Mellody M Antimicrob Agents Chemother (Bethesda); 1965; 5():267-72. PubMed ID: 5327510 [No Abstract] [Full Text] [Related]
45. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey. Gonullu N; Catal F; Kucukbasmaci O; Ozdemir S; Torun MM; Berkiten R Chemotherapy; 2009; 55(3):161-7. PubMed ID: 19390189 [TBL] [Abstract][Full Text] [Related]
46. Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: results from a children's hospital in China (2000-2004). Wang A; Yu S; Yao K; Zhang W; Yuan L; Wang Y; Wei J; Shen X; Yang Y Pediatr Pulmonol; 2008 May; 43(5):457-62. PubMed ID: 18360841 [TBL] [Abstract][Full Text] [Related]
47. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669 [TBL] [Abstract][Full Text] [Related]
48. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae. Wang D; Wang Y; Liu YN Chin Med J (Engl); 2009 Jun; 122(11):1305-10. PubMed ID: 19567142 [TBL] [Abstract][Full Text] [Related]
49. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. Jansen WT; Verel A; Beitsma M; Verhoef J; Milatovic D J Antimicrob Chemother; 2006 Oct; 58(4):873-7. PubMed ID: 16891323 [TBL] [Abstract][Full Text] [Related]
50. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
51. Combination of altered PBPs and expression of cloned extended-spectrum beta-lactamases confers cefotaxime resistance in Haemophilus influenzae. Bozdogan B; Tristram S; Appelbaum PC J Antimicrob Chemother; 2006 Apr; 57(4):747-9. PubMed ID: 16492720 [TBL] [Abstract][Full Text] [Related]
52. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733 [TBL] [Abstract][Full Text] [Related]
53. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting. Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209 [TBL] [Abstract][Full Text] [Related]
54. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Jacobs E; Dalhoff A; Korfmann G Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763 [TBL] [Abstract][Full Text] [Related]
55. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681 [TBL] [Abstract][Full Text] [Related]
56. A comparison of Etest, M.I.C.Evaluator strips and CLSI broth microdilution for determining {beta}-lactam antimicrobial susceptibility in Haemophilus influenzae. Tristram SG J Antimicrob Chemother; 2008 Dec; 62(6):1464-6. PubMed ID: 18772157 [No Abstract] [Full Text] [Related]
57. Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. Biedenbach DJ; Jones RN; Fritsche TR Diagn Microbiol Infect Dis; 2008 Jun; 61(2):240-4. PubMed ID: 18353594 [TBL] [Abstract][Full Text] [Related]